Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Lancet HIV. 2016 Apr 18;3(6):e247–e258. doi: 10.1016/S2352-3018(16)30011-X

Figure 4. Cumulative probability of an adverse event.

Figure 4

Includes all participants who started randomised study drug; time is weeks since first dose of study treatment. LPV/r=ritonavir-boosted lopinavir.

NRTI=nucleoside or nucleotide reverse transcriptase inhibitors.